| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 957 | 35.491 | 38.409 | 21.230 | 39.616 | 271.413 | 104.214 | - |
| Total Income - EUR | - | - | 957 | 35.520 | 38.531 | 21.461 | 39.915 | 275.240 | 107.448 | - |
| Total Expenses - EUR | - | - | 1.449 | 27.534 | 37.616 | 20.755 | 34.652 | 123.515 | 55.179 | - |
| Gross Profit/Loss - EUR | - | - | -492 | 7.987 | 915 | 706 | 5.263 | 151.725 | 52.269 | - |
| Net Profit/Loss - EUR | - | - | -521 | 6.922 | -237 | 69 | 4.258 | 148.168 | 51.227 | - |
| Employees | - | - | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Navscape Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 11 | 0 | 14 | 14 | 0 | 18.860 | 14.784 | - |
| Current Assets | - | - | 650 | 9.601 | 9.642 | 5.044 | 21.989 | 255.962 | 217.970 | - |
| Inventories | - | - | 104 | 166 | 4.224 | 4.144 | 9.176 | 63 | 0 | - |
| Receivables | - | - | 28 | 8.485 | 3.490 | 160 | 1.367 | 247.248 | 217.115 | - |
| Cash | - | - | 519 | 950 | 1.927 | 740 | 11.445 | 8.651 | 856 | - |
| Shareholders Funds | - | - | -477 | 6.454 | -363 | -286 | 3.978 | 152.158 | 190.701 | - |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | - | - | 1.139 | 3.185 | 10.019 | 5.344 | 18.011 | 123.198 | 43.076 | - |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5020 - 5020" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Navscape Intermed Srl